Showing results (1381-1390 of 4,511) with videos related to

Sort By:
Pageof 452
Advances in Therapy|March 13, 2021
Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future DirectionsArndt van Ophoven, Stefan Engelberg, Helen Lilley, et al.
Advances in Therapy|February 15, 2021
Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of AgeAlan G Kaplan, Jaime Correia-de-Sousa, Andrew McIvor, et al.
Advances in Therapy|March 6, 2021
Non-Invasive Respiratory Support for Management of the Perioperative Patient: A Narrative ReviewSharon Einav, Ines Lakbar, Marc Leone
Advances in Therapy|March 9, 2021
Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-AnalysisYanyan Wu, Hongyu Li, Tiansong Zhang, et al.
Advances in Therapy|February 23, 2021
Translating iGlarLixi Evidence for the Management of Frequent Clinical Scenarios in Type 2 DiabetesNeil Skolnik, Stefano Del Prato, Lawrence Blonde, et al.
Advances in Therapy|October 20, 2022
Cost-Effectiveness of Acthar Gel Versus Standard of Care for the Treatment of Exacerbations in Moderate-to-Severe Systemic Lupus ErythematosusJas Bindra, Ishveen Chopra, Kyle Hayes, et al.
Advances in Therapy|November 1, 2022
No Increased Risk of Overall Infection in Adults with Moderate-to-Severe Atopic Dermatitis Treated for up to 4 Years with DupilumabAndrew Blauvelt, Andreas Wollenberg, Lawrence F Eichenfield, et al.
Advances in Therapy|July 15, 2015
Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM StudyLaura Ordoñez-Boschetti, Roberto Rey, Ana Cruz, et al.
Advances in Therapy|September 3, 2025
Real-World Outcomes with Orelabrutinib in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Retrospective StudyZi Wang, Congwei Jia, Xuan Wang, et al.
Advances in Therapy|September 4, 2025
A Review of the Utilization of Relative Dose Intensity and Dose Delay Factor in Health Technology Appraisals of Oncology Drugs in Solid TumorsAnandaroop Dasgupta, Ankita Kaushik, Shubhram Pandey, et al.
Pageof 452